Articles dans des revues avec comité de lecture (19)
  1. 1. Verdikt, R., Bendoumou, M., Bouchat, S., Nestola, L., Pasternak, A. O., Darcis, G., Avettand-Fenoel, V., Vanhulle, C., Ait-Ammar, A., Santangelo, M., Plant, E., Douce, V. L., Delacourt, N., Cicilionyte, A., Necsoi, C., Corazza, F., Passaes, C. P. B., Schwartz, C., Bizet, M., Fuks, F., Sáez-Cirión, A., Rouzioux, C., De Wit, S., Berkhout, B., Gautier, V., Rohr, O., & Van Lint, C. (2022). Novel role of UHRF1 in the epigenetic repression of the latent HIV-1. EBioMedicine, 79, 103985. doi:10.1016/j.ebiom.2022.103985
  2. 2. Bellefroid, M., Rodari, A., Galais, M., Krijger, P., Tjalsma, S., Nestola, L., Plant, E., Vos, E., Cristinelli, S. S., Van Driessche, B., Vanhulle, C., Ait-Ammar, A., Burny, A., Ciuffi, A., De Laat, W., & Van Lint, C. (2022). Role of the cellular factor CTCF in the regulation of bovine leukemia virus latency and three-dimensional chromatin organization. Nucleic acids research, 50(6), 3190-3202. doi:10.1093/nar/gkac107
  3. 3. Kula, A., Delacourt, N., Bouchat, S., Darcis, G., Avettand-Fenoel, V., Verdikt, R., Corazza, F., Necsoi, C. V., Vanhulle, C., Bendoumou, M., Burny, A., De Wit, S., Rouzioux, C., Rohr, O., & Van Lint, C. (2019). Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments. Journal of acquired immune deficiency syndromes, 80(5), 605-613. doi:10.1097/QAI.0000000000001958
  4. 4. Fauquenoy, S., Robette, G., Kula, A., Vanhulle, C., Bouchat, S., Delacourt, N., Rodari, A., Marban, C., Schwartz, C., Burny, A., Rohr, O., Van Driessche, B., & Van Lint, C. (2017). Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites. Scientific reports, 7, 43221. doi:10.1038/srep43221
  5. 5. Darcis, G., Bouchat, S., Kula, A., Van Driessche, B., Delacourt, N., Vanhulle, C., Avettand-Fenoel, V., De Wit, S., Rohr, O., Rouzioux, C., & Van Lint, C. (2017). Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir. AIDS, 31(2), 181-189. doi:10.1097/QAD.0000000000001290
  6. 6. Bouchat, S., Delacourt, N., Kula, A., Darcis, G., Van Driessche, B., Corazza, F., Gatot, J.-S., Melard, A., Vanhulle, C., Kabeya, K., Pardons, M., Avettand-Fenoel, V., Clumeck, N., De Wit, S., Rohr, O., Rouzioux, C., & Van Lint, C. (2016). Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1. EMBO molecular medicine, 8(2), 117-138. doi:10.15252/emmm.201505557
  7. 7. Van Driessche, B., Rodari, A., Delacourt, N., Fauquenoy, S., Vanhulle, C., Burny, A., Rohr, O., & Van Lint, C. (2016). Characterization of new RNA polymerase III and RNA polymerase II transcriptional promoters in the Bovine Leukemia Virus genome. Scientific report, 6, 31125. doi:10.1038/srep31125
  8. 8. Kumar, A. A., Abbas, W., Colin, L., Khan, K. A., Bouchat, S., Varin, A., Larbi, A., Gatot, J.-S., Kabeya, K., Vanhulle, C., Delacourt, N., Pasquereau, S., Coquard, L., Borch, A., König, R., Clumeck, N., De Wit, S., Rohr, O., Rouzioux, C., Fulöp, T., Van Lint, C., & Herbein, G. (2016). Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line. Scientific reports, 6, 24090. doi:10.1038/srep24090
  9. 9. Darcis, G., Kula, A., Bouchat, S., Fujinaga, K., Corazza, F., Ait-Ammar, A., Delacourt, N., Melard, A., Kabeya, K., Vanhulle, C., Van Driessche, B., Gatot, J.-S., Cherrier, T., Pianowski, L. F., Gama, L., Schwartz, C., Vila, J., Burny, A., Clumeck, N., Moutschen, M., De Wit, S., Peterlin, M., Rouzioux, C., Rohr, O., & Van Lint, C. (2015). An In-Depth Comparison of Latency-Reversing Agent Combinations in Various in vitro and ex vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression (O. Rohr and C. Van Lint are co-last authors). PLoS pathogens, 11(7), e1005063. doi:10.1371/journal.ppat.1005063
  10. 10. Colin, L., Vandenhoudt, N., De Walque, S., Van Driessche, B., Bergamaschi, A., Martinelli, V., Cherrier, T., Vanhulle, C., Guiguen, A., David, A., Burny, A., Herbein, G., Pancino, G., Rohr, O., & Van Lint, C. (2011). The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for viral replication. PloS one, 6(4), e19084. doi:10.1371/journal.pone.0019084
  11. 11. Pierard, V., Guiguen, A., Colin, L., Wijmeersch, G., Vanhulle, C., Van Driessche, B., Dekoninck, A., Blazkova, J., Cardona, C., Merimi, M., Vierendeel, V., Calomme, C., Nguyen, T. L.-A., Nuttinck, M., Twizere, J.-C., Kettmann, R., Portetelle, D., Burny, A., Hirsch, I., Rohr, O., & Van Lint, C. (2010). DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: Potential involvement of direct inhibition of CREB/CREM/ATF transcription factor binding. The Journal of biological chemistry. doi:10.1074/jbc.M110.107607
  12. 12. Reuse, S., Calao, M., Kabeya, K., Guiguen, A., Gatot, J.-S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D., Demonte, D., Martinelli, V., Veithen, E., Cherrier, T., Avettand, V., Poutrel, S., Piette, J., De Launoit, Y., Moutschen, M., Burny, A., Rouzioux, C., De Wit, S., Herbein, G., Rohr, O., Collette, Y., Lambotte, O., Clumeck, N., & Van Lint, C. (2009). Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PloS one, 4(6), e6093. doi:10.1371/journal.pone.0006093
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 Suivant >>